First Wave BioPharma
Why Robinhood?
You can watch FWBI and buy or sell other stocks, ETFs, and their options commission-free!About FWBI
Entero Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of targeted, non-systemic therapies for the treatment of patients with gastrointestinal diseases. Its pipeline includes Latiglutenase, Capeserod, Adrulipase, and Niclosamide.
FWBI Key Statistics
Stock Snapshot
The current First Wave BioPharma(FWBI) stock price is $2.16, with a market capitalization of 3.43M. The stock trades at a price-to-earnings (P/E) ratio of -0.44.
On 2026-03-12, First Wave BioPharma(FWBI) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 204.95K.
The stock's 52-week range extends from a low of $0.97 to a high of $5.84.
The stock's 52-week range extends from a low of $0.97 to a high of $5.84.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.